Olon USA

Olon USA

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Olon USA is a well-established, private CRDMO with deep expertise in chemical process development and API manufacturing for the pharmaceutical and specialty chemical industries. Founded in 1986 and now part of the Italian Olon Group, it leverages a highly experienced technical staff and a fully integrated facility to support clients from virtual biotechs to global pharma. The company emphasizes a strong quality and compliance record, including successful FDA audits, and positions itself as a strategic partner for solving complex chemical challenges and securing U.S.-based manufacturing capacity.

Small MoleculesDrug DeliveryAntibodies

Technology Platform

Integrated contract development and manufacturing organization (CDMO) services for small molecules, combining analytical chemistry, synthetic/process chemistry, engineering, and cGMP manufacturing on a single site.

Opportunities

Growing demand for U.S.-based API manufacturing due to supply chain security concerns and potential government incentives for onshoring.
The trend towards integrated CDMO partners for efficiency presents an opportunity to capture more of the client's development value chain.

Risk Factors

Intense competition in the CDMO space could pressure margins.
Regulatory compliance failures or quality issues at its manufacturing site could severely damage reputation and business.
Reliance on the small molecule sector exposes it to shifts in pharmaceutical R&D focus towards biologics.

Competitive Landscape

Operates in the highly competitive Contract Development and Manufacturing Organization (CDMO) sector, competing with large global players (e.g., Lonza, Catalent, Thermo Fisher), specialized chemistry CDMOs (e.g., Cambrex, Sterling), and other regional U.S.-based manufacturers. Differentiates through its integrated single site, deep technical staff tenure, and strong FDA compliance record.